Cardiovascular - HPAranda® – Healthcare Professionals - GrupoFarma Ecuador

Each capsule contains Amlodipine / Losartan.


  • 2.5mg Amlodipine/ 50mg Losartan – Box x30 capsules.
  • 5mg Amlodipine/100mg Losartan – Box x30 capsules.

Treatment of arterial hypertension, in patients who do not respond to monotherapy.

One capsule a day.

Hypersensitivity to amlodipine besylate, losartan potassium or the other components of the formula. Except in special circumstances, this medicine should not be used when there is severe hypotension (amlodipine could aggravate this condition). Hypovolemic, hypernatremic patients, with impaired renal function, with hyperkalaemia or patients requiring surgery under general anesthesia. Carrier patients with stenosis of the renal artery, bilateral or in a solitary kidney.

Adverse reactions
The most commonly observed adverse effects with the use of amlodipine besylate are headache and edema; and with a lower incidence there are dizziness, facial flushing, palpitations, fatigue, nausea, drowsiness and abdominal pain.

Do not use during pregnancy or lactation. Consider using lower doses in patients with a history of hepatic dysfunction.

¡Accompanying you and your health!
We improve the level in the health of our community, through advanced medicines, own or internationally licensed.


Text text.

[contact-form-7 404 "Not Found"]

As the pioneer of the lean startup movement, APPLAUZ has dedicated it’s time to sharing effective business strategies that help new businesses and enterpreneurs put their money to work in the right way.

The information provided on this website was prepared by GrupoFarma S.A. and directed exclusively to medical personnel and health professionals. It may NOT be considered general use for people, nor as medical advice, recommendations or medical advice of any kind. We suggest not to self-medicate and consult your doctor beforehand about any concerns related to the information on the products or drugs mentioned here. Laboratories Farma S.A. will not be responsible for the misuse that third parties may give to the information obtained here.